Portola Phramaceuticals (PTLA)

[Radar_Mi]

Hi,
This is a comment of an institutional broker for another company :

"We believe cancellation of the FDA Ad Com for Ingrezza in TD was a favorable event for NBIX. The FDA's comment that it was "no longer needed" bolsters our confidence in the Ingrezza TD NDA and, in our view, outweighs the Ph2 T-Forward study of Ingrezza in adults with Tourette Syndrome (TS) which failed to meet its primary endpoint"

Why should the same decision be bearish for Portola?

As I honestly haven't understood if it's a good or bad news I would like to hear also the "other side of the moon"

Thanks in advance